ArgosBiotech - gateway to worldwide biotech

NUCLEIS

Sector:
biomedical biotech > genomics > transgenics & knockouts

Profile:
NUCLEIS, Architect in Transgenesis, is one of the world leading companies specialized in the creation of genetically modified custom made mice and associated biological services. The company offers a wide range of innovative approaches that helps researchers to better address gene discovery issues such as gene regulation and function and optimize drug developments: gene over-expression, humanized mice, knock-down (RNAi) models and knock-out/knock-in.

Products/Services:
In 2003, Nucleis launched its exclusive and innovative Speedy Mouse Technology. This unique technology combines targeted transgene insertion at hprt locus with high blastocyst colonization due to powerful patented ES cells, BPES cells. These complementary advantages guarantee the delivery of transgenic mice in 2 months with 100% chimerism, 100% germ line transmission and high predictability and reproducibility in transgene expression.

Contact

Contact Person